IDXX

#328
Idexx Laboratories Inc
582.59 USD
+1.50%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
571.07
582.59
Jahresspanne
398.75
769.98
Tagesänderung
+1.50%
Monatliche Änderung
-0.01%
6 month change
-9.00%
Jahresänderung
+43.74%
Vorheriger Schlusskurs
574.00
Eröffnung
571.50
Bid
Ask
Tief
571.07
High
582.59
Volumen
70
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
  • Market Capitalization 46.39 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
51.72
Preis-Umsatz-Verhältnis
12.76

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

Nachrichten